#21 Helen Heslop: Cellular therapy
Heslop is a professor of medicine and pediatrics and holds the Dan L Duncan Chair at Baylor. She is a physician-scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells to improve hemopoietic stem cell transplantation and cancer therapy. She has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently holds more than 20 Investigational New Drug Applications. She also has played a major role nationally as president of societies focusing on the intellectual and clinical development of cellular therapies and accreditation of facilities delivering cell therapies. Dr. Helen Heslop has been elected to the National Academy of Medicine. She is among 90 regular members and 10 international members announced today at the Academy’s annual meeting.
#21 Helen Heslop: Cellular therapy